- Pharmaxis
- Home
- Our Products
Products
Pharmaxis has a strong suite of products in development, focused on treating respiratory and autoimmune diseases. The target disease states are under-treated and many have broad patient bases.
Aridol
Overview
Pharmaxis' first commercial product, the innovative Aridol lung function test, is designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness.
By having patients inhale Aridol via a simple hand-held device, doctors can determine the severity of a patient's inflammation and prescribe the right amount of medication to bring it under control. The Aridol challenge test potentially prevents inappropriate treatment and may help patients better comply with their therapies.
Aridol is approved for sale in Australia, major European countries and Korea.
MoreBronchitol
Overview
Pharmaxis' key product in development, Bronchitol, is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions.
Pharmaxis is developing Bronchitol for diseases including bronchiectasis, cystic fibrosis and chronic bronchitis. Bronchitol hydrates the lungs, helps restore normal lung clearance, and allows patients to clear mucus more effectively. Clinical studies have shown Bronchitol to be effective and well tolerated, to improve quality of life and mucus flow in people with cystic fibrosis and bronchiectasis.
More